NM_000130.5:c.6443T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000130.5(F5):​c.6443T>C​(p.Met2148Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0422 in 1,613,552 control chromosomes in the GnomAD database, including 1,811 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.030 ( 124 hom., cov: 32)
Exomes 𝑓: 0.043 ( 1687 hom. )

Consequence

F5
NM_000130.5 missense

Scores

4
9
5

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 3.76

Publications

30 publications found
Variant links:
Genes affected
F5 (HGNC:3542): (coagulation factor V) This gene encodes an essential cofactor of the blood coagulation cascade. This factor circulates in plasma, and is converted to the active form by the release of the activation peptide by thrombin during coagulation. This generates a heavy chain and a light chain which are held together by calcium ions. The activated protein is a cofactor that participates with activated coagulation factor X to activate prothrombin to thrombin. Defects in this gene result in either an autosomal recessive hemorrhagic diathesis or an autosomal dominant form of thrombophilia, which is known as activated protein C resistance. [provided by RefSeq, Oct 2008]
F5 Gene-Disease associations (from GenCC):
  • thrombophilia due to activated protein C resistance
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • congenital factor V deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)
  • East Texas bleeding disorder
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012470007).
BP6
Variant 1-169515529-A-G is Benign according to our data. Variant chr1-169515529-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 255214.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0502 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
F5NM_000130.5 linkc.6443T>C p.Met2148Thr missense_variant Exon 24 of 25 ENST00000367797.9 NP_000121.2 P12259

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
F5ENST00000367797.9 linkc.6443T>C p.Met2148Thr missense_variant Exon 24 of 25 1 NM_000130.5 ENSP00000356771.3 P12259
F5ENST00000367796.3 linkc.6458T>C p.Met2153Thr missense_variant Exon 24 of 25 5 ENSP00000356770.3 A0A0A0MRJ7
F5ENST00000495481.1 linkn.217T>C non_coding_transcript_exon_variant Exon 1 of 2 2

Frequencies

GnomAD3 genomes
AF:
0.0305
AC:
4632
AN:
152044
Hom.:
124
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00858
Gnomad AMI
AF:
0.0428
Gnomad AMR
AF:
0.0147
Gnomad ASJ
AF:
0.0181
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0139
Gnomad FIN
AF:
0.0392
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0504
Gnomad OTH
AF:
0.0215
GnomAD2 exomes
AF:
0.0303
AC:
7611
AN:
251034
AF XY:
0.0308
show subpopulations
Gnomad AFR exome
AF:
0.00806
Gnomad AMR exome
AF:
0.0128
Gnomad ASJ exome
AF:
0.0191
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0409
Gnomad NFE exome
AF:
0.0471
Gnomad OTH exome
AF:
0.0299
GnomAD4 exome
AF:
0.0434
AC:
63460
AN:
1461390
Hom.:
1687
Cov.:
32
AF XY:
0.0427
AC XY:
31062
AN XY:
727012
show subpopulations
African (AFR)
AF:
0.00670
AC:
224
AN:
33448
American (AMR)
AF:
0.0128
AC:
573
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.0188
AC:
491
AN:
26104
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39690
South Asian (SAS)
AF:
0.0149
AC:
1288
AN:
86256
European-Finnish (FIN)
AF:
0.0418
AC:
2232
AN:
53374
Middle Eastern (MID)
AF:
0.00763
AC:
44
AN:
5768
European-Non Finnish (NFE)
AF:
0.0506
AC:
56226
AN:
1111678
Other (OTH)
AF:
0.0394
AC:
2380
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
3748
7496
11245
14993
18741
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2082
4164
6246
8328
10410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0304
AC:
4630
AN:
152162
Hom.:
124
Cov.:
32
AF XY:
0.0281
AC XY:
2091
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.00855
AC:
355
AN:
41520
American (AMR)
AF:
0.0146
AC:
223
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.0181
AC:
63
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.0139
AC:
67
AN:
4818
European-Finnish (FIN)
AF:
0.0392
AC:
415
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0504
AC:
3423
AN:
67982
Other (OTH)
AF:
0.0213
AC:
45
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
226
451
677
902
1128
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0409
Hom.:
387
Bravo
AF:
0.0278
TwinsUK
AF:
0.0537
AC:
199
ALSPAC
AF:
0.0503
AC:
194
ESP6500AA
AF:
0.0104
AC:
46
ESP6500EA
AF:
0.0447
AC:
384
ExAC
AF:
0.0305
AC:
3707
Asia WGS
AF:
0.00549
AC:
19
AN:
3478
EpiCase
AF:
0.0400
EpiControl
AF:
0.0435

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Thrombophilia due to activated protein C resistance Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital factor V deficiency Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Budd-Chiari syndrome Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Factor V deficiency Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Thrombophilia due to thrombin defect Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.68
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Uncertain
-0.030
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.57
D;T
Eigen
Uncertain
0.60
Eigen_PC
Uncertain
0.59
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Benign
0.83
T;T
MetaRNN
Benign
0.012
T;T
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Benign
1.8
L;.
PhyloP100
3.8
PrimateAI
Uncertain
0.66
T
PROVEAN
Pathogenic
-4.8
D;D
REVEL
Pathogenic
0.75
Sift
Uncertain
0.0030
D;D
Sift4G
Uncertain
0.012
D;D
Polyphen
1.0
D;.
Vest4
0.45
MPC
0.50
ClinPred
0.022
T
GERP RS
5.6
Varity_R
0.78
gMVP
0.84
Mutation Taster
=89/11
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9332701; hg19: chr1-169484767; API